DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $225,742 | -9.7% | 17,747 | 0.0% | 0.06% | -16.0% |
Q2 2023 | $249,878 | -8.9% | 17,747 | 0.0% | 0.08% | -11.8% |
Q1 2023 | $274,191 | -5.7% | 17,747 | 0.0% | 0.08% | -10.5% |
Q4 2022 | $290,873 | -11.3% | 17,747 | 0.0% | 0.10% | -18.1% |
Q3 2022 | $328,000 | +40.8% | 17,747 | 0.0% | 0.12% | +45.0% |
Q2 2022 | $233,000 | +41.2% | 17,747 | 0.0% | 0.08% | +66.7% |
Q1 2022 | $165,000 | +9.3% | 17,747 | 0.0% | 0.05% | +20.0% |
Q4 2021 | $151,000 | -75.0% | 17,747 | 0.0% | 0.04% | -78.1% |
Q3 2021 | $603,000 | -7.2% | 17,747 | 0.0% | 0.18% | -9.4% |
Q2 2021 | $650,000 | -18.3% | 17,747 | 0.0% | 0.20% | -23.5% |
Q1 2021 | $796,000 | -1.2% | 17,747 | 0.0% | 0.26% | -1.9% |
Q4 2020 | $806,000 | -55.7% | 17,747 | -50.0% | 0.27% | -29.0% |
Q3 2020 | $1,820,000 | -14.2% | 35,494 | 0.0% | 0.38% | -17.6% |
Q2 2020 | $2,120,000 | +45.0% | 35,494 | 0.0% | 0.46% | +23.7% |
Q1 2020 | $1,462,000 | +32.3% | 35,494 | +100.0% | 0.37% | -17.0% |
Q4 2019 | $1,105,000 | -8.2% | 17,747 | -50.0% | 0.45% | +77.1% |
Q3 2019 | $1,204,000 | +41.3% | 35,494 | 0.0% | 0.25% | +43.8% |
Q2 2019 | $852,000 | +106.8% | 35,494 | +100.0% | 0.18% | +2.9% |
Q1 2019 | $412,000 | -44.8% | 17,747 | -50.0% | 0.17% | -1.7% |
Q4 2018 | $746,000 | +8.6% | 35,494 | +100.0% | 0.17% | -38.1% |
Q3 2018 | $687,000 | -1.6% | 17,747 | 0.0% | 0.28% | -7.6% |
Q2 2018 | $698,000 | – | 17,747 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |